Trading Signals: EYES Stock Price Prediction and Forecast (Thu. Mar. 10, 2016 - Mon. Jun. 28, 2021)(Second Sight Medical Products Inc)
| EYES latest price $8.8000 (0.57%) ($8.8000 - $8.8000) on Thu. Mar. 25, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 42.36% (three month average) | RSI | 70 | Latest Price | $8.8000(0.57%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EYES declines -9.8% a day on average for past five trading days. | Weekly Trend | EYES declines -1.8% a week on average for past two weeks. | Market Behavior | Value stock rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support EYES advance at 0% a week (0% probability) KWEB(37%) MCHI(34%) FXI(28%) ONLN(21%) GDXJ(19%) | Factors Impacting EYES price | EYES will decline at least -21.18% in a week (0% probabilities). CEMB(-88%) TIP(-44%) TLT(-40%) JNK(-37%) VCIT(-34%) | | | | | Relative Volatility | | | | Market Trend Strength | -21.18% (StdDev 42.36%) | Hourly BBV | -0.6 () | Intraday Trend | 0% | | | |
|
Resistance Level | $9.81 | 5 Day Moving Average | $11.1(-20.72%) | 10 Day Moving Average | $12.66(-30.49%) | 20 Day Moving Average | $9.81(-10.3%) | To recent high | -43.2% | To recent low | 52% | Market Cap | $2.811b | | | | Second Sight Medical Products, Inc. (NASDAQ: EYES) develops, manufactures and markets implantable visual prosthetics that are intended to deliver useful artificial vision to blind individuals. A recognized global leader in neuromodulation devices for blindness, the Company is committed to developing new technologies to treat the broadest population of sight-impaired individuals. The Company's headquarters are in Los Angeles, California. |